Bulk Manufacturer of Controlled Substances Application: Purisys, LLC., 32976-32977 [2021-13096]
Download as PDF
<![CDATA[
32976
Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices
comments received will be provided to
the Council.
Public Disclosure of Comments:
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Detailed Council meeting minutes
will be maintained in the Green River
District Office and will be available for
public inspection and reproduction
during regular business hours within 90
days following each meeting. Minutes
will also be posted to the Council web
page.
Authority: 43 CFR 1784.4–2.
Gregory Sheehan,
State Director.
[FR Doc. 2021–13112 Filed 6–22–21; 8:45 am]
BILLING CODE 4310–DQ–P
JOINT BOARD FOR THE
ENROLLMENT OF ACTUARIES
Meeting of the Advisory Committee;
Meeting
Joint Board for the Enrollment
of Actuaries.
ACTION: Notice of federal advisory
committee meeting.
AGENCY:
The Joint Board for the
Enrollment of Actuaries gives notice of
a teleconference meeting of the
Advisory Committee on Actuarial
Examinations (a portion of which will
be open to the public) on July 8 and 9,
2021.
DATES: Thursday, July 8, 2021, from 9:00
a.m. to 5:00 p.m. (EDT), and Friday, July
9, 2021, from 8:30 a.m. to 5:00 p.m.
(EDT).
ADDRESSES: The meeting will be held by
teleconference.
FOR FURTHER INFORMATION CONTACT: Ms.
Elizabeth Van Osten, Designated Federal
Officer, Advisory Committee on
Actuarial Examinations, at (202) 317–
3648 or Elizabeth.j.vanosten@irs.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Advisory
Committee on Actuarial Examinations
will meet by teleconference on
Thursday, July 8, 2021, from 9:00 a.m.
to 5:00 p.m. (EDT), and Friday, July 9,
2021, from 8:30 a.m. to 5:00 p.m. (EDT).
The purpose of the meeting is to
discuss topics and questions that may
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:13 Jun 22, 2021
Jkt 253001
be recommended for inclusion on future
Joint Board examinations in actuarial
mathematics and methodology referred
to in 29 U.S.C. 1242(a)(1)(B) and to
review the May 2021 Pension (EA–2L)
and Basic (EA–1) Examinations in order
to make recommendations relative
thereto, including the minimum
acceptable pass scores. Topics for
inclusion on the syllabus for the Joint
Board’s examination program for the
November 2021 Pension (EA–2F)
Examination will be discussed.
A determination has been made as
required by section 10(d) of the Federal
Advisory Committee Act, 5 U.S.C. App.,
that the portions of the meeting dealing
with the discussion of questions that
may appear on the Joint Board’s
examinations and the review of the May
2021 EA–2L and EA–1 Examinations
fall within the exceptions to the open
meeting requirement set forth in 5
U.S.C. 552b(c)(9)(B), and that the public
interest requires that such portions be
closed to public participation.
The portion of the meeting dealing
with the discussion of the other topics
will commence at 1:00 p.m. (EDT) on
July 8, 2021, and will continue for as
long as necessary to complete the
discussion, but not beyond 3:00 p.m.
(EDT). Time permitting, after the close
of this discussion by Committee
members, interested persons may make
statements germane to this subject.
Persons wishing to make oral statements
should contact the Designated Federal
Officer at NHQJBEA@IRS.GOV and
include the written text or outline of
comments they propose to make orally.
Such comments will be limited to 10
minutes in length. Persons who wish to
attend the public session should contact
the Designated Federal Officer at
NHQJBEA@IRS.GOV to obtain
teleconference access instructions.
Notifications of intent to make an oral
statement or to attend the meeting must
be sent electronically to the Designated
Federal Officer by no later than July 1,
2021. In addition, any interested person
may file a written statement for
consideration by the Joint Board and the
Advisory Committee by sending it to
NQJBEA@IRS.GOV.
DEPARTMENT OF JUSTICE
Dated: June 17, 2021.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the
Enrollment of Actuaries.
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. The company plans to
manufacture the above-listed controlled
substances as clinical trial and starting
materials to make compounds for
distribution to its customers. No other
[FR Doc. 2021–13174 Filed 6–22–21; 8:45 am]
BILLING CODE 4830–01–P
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–856]
Bulk Manufacturer of Controlled
Substances Application: Purisys, LLC.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Purisys, LLC. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 23, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March, 12, 2021,
Purisys, LLC., 1550 Olympic Drive,
Athens, Georgia 30601–1602, applied to
be registered as a bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
3,4Methylenedioxyamphetamine.
3,4Methylenedioxymethamphetamine.
3,4-Methylenedioxy-Nethylamphetamine.
Psilocybin ........................
Psilocyn ...........................
E:\FR\FM\23JNN1.SGM
23JNN1
Drug
code
Schedule
7400
I
7404
I
7405
I
7437
7438
I
I
Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices
other forms of information technology,
e.g., permitting electronic submission of
responses.
activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–13096 Filed 6–22–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1122–0006]
Agency Information Collection
Activities; Proposed eCollection
Requested; Extension of a Currently
Approved Collection
Office on Violence Against
Women, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice,
Office on Violence Against Women
(OVW) will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 23, 2021.
FOR FURTHER INFORMATION CONTACT:
Written comments and/or suggestion
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to Cathy Poston,
Office on Violence Against Women, at
202–514–5430 or Catherine.poston@
usdoj.gov.
SUMMARY:
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:13 Jun 22, 2021
Jkt 253001
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of currently approved
collection.
(2) Title of the Form/Collection:
Semiannual Progress Report for the
Improving Criminal Justice Responses to
Sexual Assault, Domestic Violence,
Dating Violence, and Stalking Grant
Program.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: 1122–0006.
U.S. Department of Justice, Office on
Violence Against Women.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: The affected public includes
200 grantees from the Improving
Criminal Justice Responses to Sexual
Assault, Domestic Violence, Dating
Violence, and Stalking Grant Program
(ICJR Program) (also known as Grants to
Encourage Arrest Policies and
Enforcement of Protection Orders)
which encourages state, local, and tribal
governments and state, local, and tribal
courts to treat domestic violence, dating
violence, sexual assault, and stalking as
serious violations of criminal law
requiring the coordinated involvement
of the entire criminal justice system.
Eligible applicants are states and
territories, units of local government,
Indian tribal governments, coalitions,
victim service providers and state, local,
tribal, and territorial courts.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that it will
take the approximately 200 respondents
(ICJR Program grantees) approximately
one hour to complete a semi-annual
progress report. The semi-annual
progress report is divided into sections
that pertain to the different types of
activities in which grantees may engage.
An ICJR Program grantee will only be
required to complete the sections of the
form that pertain to its own specific
activities (victim services, law
enforcement, training, etc.).
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total annual hour burden
to complete the data collection forms is
400 hours, that is 200 grantees
completing a form twice a year with an
estimated completion time for the form
being one hour.
If additional information is required
contact: Melody Braswell, Deputy
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
32977
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E, 405B,
Washington, DC 20530.
Dated: June 17, 2021.
Melody Braswell,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. 2021–13168 Filed 6–22–21; 8:45 am]
BILLING CODE 4410–FX–P
DEPARTMENT OF LABOR
Notice of Update to the Department of
Labor’s List of Goods Produced by
Child Labor or Forced Labor
The Bureau of International
Labor Affairs, United States Department
of Labor.
ACTION: Notice: Announcement of
public availability of updated list of
goods produced by child labor or forced
labor.
AGENCY:
This notice announces the
publication of an update to the list of
goods—along with countries of origin—
that the Bureau of International Labor
Affairs (ILAB) has reason to believe are
produced by child labor or forced labor
in violation of international standards
(the List). ILAB is required to develop
and make available to the public the List
pursuant to the Trafficking Victims
Protection Reauthorization Act (TVPRA
of 2005), amended.
FOR FURTHER INFORMATION CONTACT:
Director, Office of Child Labor, Forced
Labor, and Human Trafficking, Bureau
of International Labor Affairs, U.S.
Department of Labor at (202) 693–4843
(this is not a toll free number) or ILABTVPRA@dol.gov. Individuals with
hearing or speech impairments may
access the telephone number above via
TTY by calling the Federal Information
Relay Service at 1–877–889–5627.
SUPPLEMENTARY INFORMATION: The
Bureau of International Labor Affairs
(ILAB) announces an update to the
ninth edition of the List of Goods
Produced by Child Labor or Forced
Labor (List), pursuant to the Trafficking
Victims Protection Reauthorization Act
(TVPRA) of 2005, as amended (TVPRA).
ILAB published the initial List on
September 10, 2009, and has since
published nine updated editions. This
2021 update to the ninth edition
contains one additional good
(polysilicon) from one country (China).
Section 105(b) of the Trafficking
Victims Protection Reauthorization Act
of 2005 (‘‘TVPRA of 2005’’), Public Law
SUMMARY:
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Pages 32976-32977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13096]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-856]
Bulk Manufacturer of Controlled Substances Application: Purisys,
LLC.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Purisys, LLC. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 23, 2021.
Such persons may also file a written request for a hearing on the
application on or before August 23, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March, 12, 2021, Purisys, LLC., 1550 Olympic Drive,
Athens, Georgia 30601-1602, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
3,4-Methylenedioxyamphetamine........... 7400 I
3,4-Methylenedioxymethamphetamine....... 7404 I
3,4-Methylenedioxy-N-ethylamphetamine... 7405 I
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the internal use intermediates or for sale to its
customers. The company plans to manufacture the above-listed controlled
substances as clinical trial and starting materials to make compounds
for distribution to its customers. No other
[[Page 32977]]
activity for these drug codes is authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-13096 Filed 6-22-21; 8:45 am]
BILLING CODE P
